Skip to main content

Advertisement

SpringerLink
Log in

Non-enhancing de novo glioblastoma: report of two cases

  • Neurooncology
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Malignant gliomas arise from two distinct pathways, as de novo lesions or from secondary transformation from low-grade lesions. Herein, we describe the cases of two patients to illustrate the proposition that de novo malignant gliomas can originate as non-enhancing tumors and rapidly progress to a pattern of ring enhancement characteristic of a glioblastoma. Both patients presented with new-onset seizures (simple partial and generalized). Their neurological examinations were unremarkable. Initial MRI evaluations revealed a right precentral gyrus and right medial temporal lobe lesions in each case, respectively. These lesions demonstrated increased T2 signal changes without contrast enhancement. The biopsy of the right frontal lesion in the first patient was consistent with an anaplastic astrocytoma; the second patient was followed expectantly. Repeat MRI for both patients within 17 weeks disclosed ring-enhancing lesions, consistent with an unusually rapid evolution to glioblastoma multiforme (GBM). Subsequent resection of the right medial temporal lesion in the second patient revealed a GBM. Neither tumor displayed abnormal overexpression of P53 by immunohistochemistry. Early MRI of de novo glioblastomas may demonstrate a non-enhancing tumor suggestive of a low-grade lesion. These tumors can rapidly evolve into ring-enhancing lesions more consistent with the traditional imaging findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Afra D, Osztie E, Sipos L, Vitanovics D (1999) Preoperative history and postoperative survival of supratentorial low-grade astrocytomas. Br J Neurosurg 13:299–305

    Article  CAS  PubMed  Google Scholar 

  2. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T (1994) Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 36:308–310

    CAS  PubMed  Google Scholar 

  3. Barker FG II, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD (1997) Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 80:936–941

    Article  PubMed  Google Scholar 

  4. Bolender NF, Cromwell LD, Graves V, Margolis MT, Kerber CW, Wendling L (1983) Interval appearance of glioblastomas not evident in previous CT examinations. J Comput Assist Tomogr 7:599–603

    CAS  PubMed  Google Scholar 

  5. Chamberlain MC, Murovic JA, Levin VA (1988) Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38:1371–1374

    CAS  PubMed  Google Scholar 

  6. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD et al (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77:295–301

    PubMed  Google Scholar 

  7. Earnest Ft, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, Forbes GS, Axley PL (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827

    PubMed  Google Scholar 

  8. Fujimoto M, Fults DW, Thomas GA, Nakamura Y, Heilbrun MP, White R, Story JL, Naylor SL, Kagan-Hallet KS, Sheridan PJ (1989) Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4:210–214

    CAS  PubMed  Google Scholar 

  9. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF (1998) The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 49:436–440

    Article  CAS  PubMed  Google Scholar 

  10. Graif M, Bydder GM, Steiner RE, Niendorf P, Thomas DG, Young IR (1985) Contrast-enhanced MR imaging of malignant brain tumors. Am J Neuroradiol 6:855–862

    CAS  PubMed  Google Scholar 

  11. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65–73

    CAS  PubMed  Google Scholar 

  12. Huncharek M, Kupelnick B (2000) Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis. Oncol Res 12:107–112

    CAS  PubMed  Google Scholar 

  13. Inaba Y, Hiratsuka H, Komatsu K (1978) Computed tomography of the head: clinical experience of the first 3000 scans with EMI scanner. Bull Tokyo Med Dent Univ 25:157–164

    CAS  PubMed  Google Scholar 

  14. Kimmelman AC, Ross DA, Liang BC (1996) Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 34:250–254

    Article  CAS  PubMed  Google Scholar 

  15. Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533–536

    CAS  PubMed  Google Scholar 

  16. Lewander R (1979) Contrast enhancement with time in gliomas. Stereotactic computer tomography following contrast medium infusion. Acta Radiol Diagn 20:689–672

    CAS  Google Scholar 

  17. Lote K, Egeland T, Hager B, Skullerud K, Hirschberg H (1998) Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neurooncol 40:161–170

    Article  CAS  PubMed  Google Scholar 

  18. Mihara F (1992) Non-contrast-enhancing supratentorial malignant astrocytoma: MR diagnosis. 30th Annual Meeting of the American Society of Neuroradiology, St Louis, MO

  19. Moore-Stovall J, Venkatesh R (1993) Serial nonenhancing magnetic resonance imaging scans of high grade glioblastoma multiforme. J Natl Med Assoc 85:122–128

    CAS  PubMed  Google Scholar 

  20. Okamoto K, Ito J, Takahashi N, Ishikawa K, Furusawa T, Tokiguchi S, Sakai K (2002) MRI of high-grade astrocytic tumors: early appearance and evolution. Neuroradiology 44:395–402

    Article  CAS  PubMed  Google Scholar 

  21. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC (1993) CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 61:105–117

    CAS  PubMed  Google Scholar 

  22. Perry JR, Tien RD, McLendon RE, Rasheer K, Brown MT (1996) Argument for stereotactic biopsy of suspected low-grade glioma: results from 53 nonenhancing lesions. Neurology 46

  23. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, Lacy J, Tsukerman L, Makuch R (1996) Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 38:872–878; discussion 878–879

    CAS  PubMed  Google Scholar 

  24. Pierallini A, Bonamini M, Bozzao A, Pantano P, Stefano DD, Ferone E, Raguso M, Bosman C, Bozzao L (1997) Supratentorial diffuse astrocytic tumours: proposal of an MRI classification. Eur Radiol 7:395–399

    Article  CAS  PubMed  Google Scholar 

  25. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31:431–436

    CAS  PubMed  Google Scholar 

  26. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA (2002) How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947–949

    CAS  PubMed  Google Scholar 

  27. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O’Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93:1246–1256

    Article  CAS  PubMed  Google Scholar 

  28. Tada K, Shiraishi S, Kamiryo T, Nakamura H, Hirano H, Kuratsu J, Kochi M, Saya H, Ushio Y (2001) Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival. J Neurosurg 95:651–659

    CAS  PubMed  Google Scholar 

  29. Torp SH, Helseth E, Dalen A, Unsgaard G (1992) Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir 117:182–186

    CAS  Google Scholar 

  30. Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463–469

    CAS  PubMed  Google Scholar 

  31. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and P53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217–223

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA

    Aaron A. Cohen-Gadol, Michael L. DiLuna, Joseph M. Piepmeier & Dennis D. Spencer

  2. Department of Neurologic Surgery, Joseph 1-229, Saint Mary’s Hospital, 1216 Second Street SW, Rochester, MN 55905, USA

    Aaron A. Cohen-Gadol

  3. Department of Pathology, Yale University School of Medicine, New Haven, CT, USA

    Sergei I. Bannykh

Authors
  1. Aaron A. Cohen-Gadol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael L. DiLuna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sergei I. Bannykh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph M. Piepmeier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dennis D. Spencer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aaron A. Cohen-Gadol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen-Gadol, A.A., DiLuna, M.L., Bannykh, S.I. et al. Non-enhancing de novo glioblastoma: report of two cases. Neurosurg Rev 27, 281–285 (2004). https://doi.org/10.1007/s10143-004-0346-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-004-0346-5

Keywords

Search

Navigation